Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Clinical

More Than the Sum of Parts: A Roadmap to Target Social Risk Factors in Rheumatology

Tuesday, October 28, 2025
4:00 PM – 5:00 PM Central Time

    Moderator(s)

  • CF

    Candace Feldman, MD, MPH, ScD

    Brigham and Women's Hospital
    Boston, Massachusetts, United States

    Disclosure(s): Bain Capital, LP: Consultant (Ongoing); BMS Foundation: Grant/Research Support (Ongoing); Bristol-Myers Squibb Foundation: Grant/Research Support (Ongoing); Curio Bioscience: My husband is one of the founders and will receive equity (but has not received anything to date). (Ongoing); Harvard Pilgrim: Consultant (Ongoing); OM1, Inc.: Consultant (Ongoing); Pfizer: Grant/Research Support (Ongoing); Pfizer Pharmaceuticals: Grant/Research Support (Ongoing)

    • Session Coordinator(s)

  • RS

    Reema Syed, MD, MBBS

    Washington University School of Medicine in Saint Louis
    olivette, Missouri, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • AA

    Anca Askanase, MD, MPH

    Director
    Columbia University Medical Center
    New York, New York, United States

    Disclosure(s): Alumis: Advisor or Review Panel Member (Ongoing); Amgen: Advisor or Review Panel Member (Terminated, August 15, 2024); AstraZeneca: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Idorsia: Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing); NKARTA: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Sanofi: Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing)

  • KS

    Kai Sun, MD,MS,RhMSUS

    Duke University
    Durham, North Carolina, United States

    Disclosure(s): Aurinia: Consultant (Terminated)

This session will bring experts to share their experiences to: 1) identify key social risk factors that drive health disparities, 2) develop a roadmap to partner with health system administrators, social services, and policymakers to garner support for key services to address social risk factors in rheumatology-focused healthcare settings, and 3) implement and evaluate interventions that target adverse social barriers in rheumatology clinics and develop strategies to collaborate across diverse clinical practices, including low resource settings.

Learning Objectives:

  • Identify gold standard validated tools to screen for social determinants of health (SDOH) that can impact health outcomes and drive inequities in outcome
  • Apply expertise in partnering with health systems administrators and advocates to garner support to address SDOH in rheumatology clinics
  • Strategize how to address social risk factors in rheumatic diseases and learn about interventions used in diverse rheumatology clinics, including those with low resources
  • Discuss methods to measure quality performance and success of collaborative initiatives using the electronic health record

Presentations:

  • 4:00 PM – 5:00 PM Central Time
    Panel Discussion

    Panelist: Jennifer Rogers, MD – Duke

    Panelist: Kimberly DeQuattro, MD – University of Pennsylvania

    Panelist: Shivani Garg, MD, MS – University of Madison, School of Medicine and Public Health